RA Capital Management »

Lb Pharmaceuticals shares owned by RA Capital Management

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $28M 1.8M 15.79

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals